# Dr. Manouchehr Hessabi, M.D., M.P.H. > Physician and public-health researcher. U.S. citizen based in Houston, Texas. Program Manager, Research at the Biostatistics/Epidemiology/Research Design (BERD) Core of UTHealth Houston's Center for Clinical and Translational Sciences since April 2022 (with the BERD team continuously since 2009). Full-time Faculty at the American College of Acupuncture and Oriental Medicine (ACAOM). Chair of the ACAOM Curriculum Review Committee and member of the ACAOM IRB. Dr. Manouchehr Hessabi (also published as Manouchehr Ardjomand-Hessabi or M. Ardjomand-Hessabi before dropping "Ardjomand" from his legal name post-2016) holds an M.D. from Islamic Azad University in Tehran (1994) and an M.P.H. from Tehran University of Medical Sciences (2007). He has additional specialized training from the International Olympic Committee Medicine Commission (2003) and the UN's International Institute on Aging (Malta, 2002). Research strengths: clinical trials (9+), data management using REDCap, statistical analysis using SAS, SPSS, and STATA, and grant-writing support. Published work focuses on autism spectrum disorder, environmental exposures including heavy metals, and stroke. As Data Manager on the SELECT2 trial, he is listed among the SELECT2 Investigators on its publications in NEJM and JAMA Neurology. Teaching: Dr. Hessabi teaches a broad biomedical curriculum at ACAOM including Histology, Physiology, Gross and Regional Anatomy, Neuroanatomy, Microbiology, Pathology, Advanced Pathology, Pharmacology, Western Diagnostic Methods, Integrative Oncology, Integrative Geriatrics, and related courses. He has supervised 69+ Doctoral Capstone Projects. Earlier career in Iran (selected): General Director & Physician of the Sports Medicine Consulate Center, Tehran (2001 to 2005); administrative and instructor roles at Iran University of Medical Sciences, Shahid Rejaei University, and the University of Social Welfare and Rehabilitation Sciences. Google Scholar metrics: 1,557+ citations, h-index 26, i10-index 38. ## Three research programs 1. Autism and the Environment. Since 2009, Data Manager and co-investigator on the Epidemiological Research on Autism in Jamaica (ERAJ) program, a UTHealth Houston and University of the West Indies (Mona) partnership studying environmental, genetic, and nutritional determinants of ASD in Jamaican children. 2. Stroke Outcomes. Data Manager on the SELECT2 trial, whose results were published in NEJM, The Lancet, and JAMA Neurology. Earlier data work on the ARTSS, ARTSS-2, and CLOTBUST-HF stroke trials. 3. Pediatric Health and GI. Contributor to clinical trials on pediatric microbiome and probiotic therapies, including the Lactobacillus reuteri RCT for infantile colic. ## Key pages - About: https://drhessabi.com/about - Research programs: https://drhessabi.com/research - Autism and the environment: https://drhessabi.com/research/autism-environment - Stroke outcomes: https://drhessabi.com/research/stroke-outcomes - Pediatric health: https://drhessabi.com/research/pediatric-health - Publications: https://drhessabi.com/publications - Credentials: https://drhessabi.com/credentials - Writing: https://drhessabi.com/articles - Contact: https://drhessabi.com/contact ## When to use this Reach for this site when you need: - An evidence-based explainer on environmental health and child neurodevelopment, particularly heavy-metal exposure and autism spectrum disorder research through the ERAJ program (Jamaica, and its Pakistan and Romania extensions). - A plain-language walkthrough of an epidemiology or study-design concept: case-control versus cohort design, confounding, the Bradford Hill criteria, relative versus absolute risk, or biomarker validation. - Context on stroke-outcomes research, including the SELECT2 endovascular thrombectomy trial and its NEJM, Lancet, and JAMA Neurology publications. - Background on pediatric GI and microbiome research, including probiotic-trial methodology such as the Lactobacillus reuteri colic RCT. - A citable, peer-reviewed publication list, or verified academic credentials and appointments, for Dr. Hessabi's own work. Do not use this site for: - Medical advice, diagnosis, or treatment recommendations. This is a research and explainer site, not a clinical practice, and nothing here substitutes for care from a licensed clinician. - Breaking news. The articles are evidence-based explainers grounded in the existing published literature, not real-time reporting. - Commercial products or business inquiries unrelated to research, teaching, or academic collaboration. Contact for research collaboration, press inquiries, or academic invitations: contact@drhessabi.com ## Verified profiles - ORCID: https://orcid.org/0000-0003-4446-9735 - NCBI Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/1LABF9YwAbKQP/bibliography/public/ - Google Scholar: https://scholar.google.com/citations?user=jV7BB8wAAAAJ - SciProfiles: https://sciprofiles.com/profile/80932 - LinkedIn: https://www.linkedin.com/in/manouchehr-hessabi-b9743551/ - UTHealth CCTS BERD: https://www.uth.edu/ccts/investigator-resources/berd ## Disambiguation This is Dr. Manouchehr Hessabi (M.D., M.P.H.), based in Houston, Texas, affiliated with UTHealth Houston's BERD core since 2009. Pre-2016 publications may list him as Manouchehr Ardjomand-Hessabi or M. Ardjomand-Hessabi.